XML 26 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2014
Fair Value Measurements  
Schedule of available-for-sale securities and derivative financial instruments measured at fair value

The fair value of the Company’s available-for-sale securities and derivative financial instruments was determined using the following inputs (amounts in thousands):

 

 

 

 

 

Carrying and

 

Fair Value Measurements
Using Fair Value Hierarchy
on a Recurring Basis

 

 

 

As of

 

Fair Value

 

Level 1

 

Level 2

 

Financial assets:

 

 

 

 

 

 

 

 

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

Equity securities

 

March 31, 2014

 

$

287

 

$

287

 

$

 

 

 

December 31, 2013

 

282

 

282

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial instruments:

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

March 31, 2014

 

214

 

 

214

 

 

 

December 31, 2013

 

265

 

 

265

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities:

 

 

 

 

 

 

 

 

 

Derivative financial instruments:

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

March 31, 2014

 

1,441

 

 

1,441

 

 

 

December 31, 2013

 

774

 

 

774

 

Schedule of effect of derivative financial instruments on statement of income

The following table presents the effect of the Company’s derivative financial instruments on the statement of income for the periods presented (amounts in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2014

 

2013

 

Consolidated

 

 

 

 

 

Amount of (loss) income recognized on derivatives in Other comprehensive (loss)

 

$

(1,106

)

$

26

 

Amount of (loss) reclassification from Accumulated other comprehensive (loss) into Interest expense

 

(388

)

(152

)

 

 

 

 

 

 

Joint Ventures (Company’s share)

 

 

 

 

 

Amount of (loss) gain recognized on derivative in Other comprehensive (loss)

 

(7

)

(4

)

Amount of (loss) reclassification from Accumulated other comprehensive (loss) into Equity in earnings of unconsolidated joint ventures

 

(14

)

(14

)